Nurix Therapeutics
NRIX
NRIX
113 hedge funds and large institutions have $1.18B invested in Nurix Therapeutics in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 32 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 103 → 113 (+10)
3% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 32
0.25% less ownership
Funds ownership: 89.11% → 88.86% (-0.25%)
Holders
113
Holding in Top 10
9
Calls
$204K
Puts
$13K
Top Buyers
| 1 | +$20M | |
| 2 | +$15.3M | |
| 3 | +$11.9M | |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$9.12M |
| 5 |
O
OrbiMed
New York
|
+$8.35M |
Top Sellers
| 1 | -$30M | |
| 2 | -$25.2M | |
| 3 | -$9.09M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$6.78M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$6.48M |